Kala Pharmaceuticals, Inc.
9 clinical trials · Sponsor
◉ Watch Kala Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children (NCT03596723) | Kala Pharmaceuticals, Inc. | 2018-07-03 |
Track Kala Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.